Načítá se...
Outcome of small cell lung cancer (SCLC) patients with brain metastases in a routine clinical setting
BACKGROUND: Small cell lung cancer (SCLC) represents approximately 13 to 18% of all lung cancers. It is the most aggressive among lung cancers, mostly presented at an advanced stage, with median survival rates of 10 to12 months in patients treated with standard chemotherapy and radiotherapy. In appr...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Versita, Warsaw
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3423766/ https://ncbi.nlm.nih.gov/pubmed/22933980 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2478/v10019-012-0007-1 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|